|
ZA9610949B
|
|
Monoglyceride compositions and their use against Helicobacter.
|
|
WO9710801A2
|
|
Nisin compositions to prevent the promotion of tooth decay by suppressing formation of acid from foods by oral bacteria
|
|
ZA9604329B
|
|
Method of using lantibiotics in a bactericidal role to effect destruction of listeria monocytogenes in processed crustacean species
|
|
HU9500561A3
|
|
Pharmaceutical bacteriocin compositions and methods for using the same
|
|
HU9500563A3
|
|
Pharmaceutical bacteriocin compositions and methods for using the same
|
|
US5304540A
|
|
Pharmaceutical bacteriocin compositions and methods for using the same
|
|
US5334582A
|
|
Pharmaceutical bacteriocin compositions and methods for using the same
|
|
BR9305754A
|
|
Bacteriocin pharmaceutical compositions
|
|
ZA9300245B
|
|
Pharmaceutical bacteriocin compositions and methods for using the same
|
|
US5260271A
|
|
Nisin compositions for use as enhanced broad range bactericides
|
|
AU665188B2
|
|
Pharmaceutical compositions against gastric disorders
|
|
US5217950A
|
|
Nisin compositions for use as enhanced, broad range bactericides
|
|
IL87686D0
|
|
Compositions for treating staphylococcal infections and methods for treating bovine staphylococcal mastitis
|
|
IE63009B1
|
|
Method of treating mastitis and other staphylococcal infections
|
|
CA1330758C
|
|
Method of treating mastitis and other staphylococcal infections
|
